Lupin acquires GAVIS - MarketLine Financial Deals

Lupin acquires GAVIS

Lupin acquires GAVIS - MarketLine Financial Deals
Lupin acquires GAVIS
Published Mar 09, 2016
3 pages — Published Mar 09, 2016
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Lupin Limited, an India-based pharmaceutical company, has acquired GAVIS Pharmaceuticals LLC and Novel Laboratories, Inc.

  
Source:
Document ID
MA157285_150727
Country
Country
Ticker
500257=IN
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Lupin acquires GAVIS" Mar 09, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Lupin-acquires-GAVIS-2052-111014>
  
APA:
MarketLine Financial Deals. (2016). Lupin acquires GAVIS Mar 09, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Lupin-acquires-GAVIS-2052-111014>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.